Stay updated on Anti-PD1 Combo with Tisagenlecleucel in ALL Clinical Trial
Sign up to get notified when there's something new on the Anti-PD1 Combo with Tisagenlecleucel in ALL Clinical Trial page.

Latest updates to the Anti-PD1 Combo with Tisagenlecleucel in ALL Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedAdded a new revision entry 'Revision: v3.3.3' to the study record history; removed the 'HHS Vulnerability Disclosure' link and the 'Revision: v3.3.2' entry.SummaryDifference0.2%

- Check17 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedA new revision entry (v3.3.2) was added to the record history, following the previous v3.3.1.SummaryDifference0.1%

- Check39 days agoChange DetectedSite revision updated from v3.2.0 to v3.3.1; no changes to the study record content or data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check46 days agoChange DetectedThe page history shows a deletion of the notice about potential delays due to lapse in government funding and the NIH operating status; this banner previously appeared at the top of the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check60 days agoChange DetectedNew version 2024-05-26 added to the record history, listing updates to Recruitment Status and Study Status. This provides visibility into the current activity of the trial.SummaryDifference0.1%

- Check89 days agoChange DetectedAdditions introduce a government funding notice and confirm the NIH Clinical Center is open, plus a v3.2.0 revision; deletions remove v3.1.0.SummaryDifference13%

Stay in the know with updates to Anti-PD1 Combo with Tisagenlecleucel in ALL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Anti-PD1 Combo with Tisagenlecleucel in ALL Clinical Trial page.